Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Prev Cardiol ; 28(13): 1501-1507, 2021 10 25.
Article in English | MEDLINE | ID: mdl-34695216

ABSTRACT

BACKGROUND: Environmental pollution and weather changes unfavorably impact on cardiovascular disease. However, limited research has focused on ST-elevation myocardial infarction (STEMI), the most severe yet distinctive form of acute coronary syndrome. METHODS AND RESULTS: We appraised the impact of environmental and weather changes on the incidence of STEMI, analysing the bivariate and multivariable association between several environmental and atmospheric parameters and the daily incidence of STEMI in two large Italian urban areas. Specifically, we appraised: carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NOX), ozone, particulate matter smaller than 10 µm (PM10) and than 2.5 µm (PM2.5), temperature, atmospheric pressure, humidity and rainfall. A total of 4285 days at risk were appraised, with 3473 cases of STEMI. Specifically, no STEMI occurred in 1920 (44.8%) days, whereas one or more occurred in the remaining 2365 (55.2%) days. Multilevel modelling identified several pollution and weather predictors of STEMI. In particular, concentrations of CO (p = 0.024), NOX (p = 0.039), ozone (p = 0.003), PM10 (p = 0.033) and PM2.5 (p = 0.042) predicted STEMI as early as three days before the event, as well as subsequently, and NO predicted STEMI one day before (p = 0.010), as well as on the same day. A similar predictive role was evident for temperature and atmospheric pressure (all p < 0.05). CONCLUSIONS: The risk of STEMI is strongly associated with pollution and weather features. While causation cannot yet be proven, environmental and weather changes could be exploited to predict STEMI risk in the following days.


Subject(s)
Air Pollutants , Air Pollution , ST Elevation Myocardial Infarction , Air Pollutants/adverse effects , Air Pollution/adverse effects , Environmental Pollution/analysis , Humans , Incidence , Particulate Matter/adverse effects , ST Elevation Myocardial Infarction/diagnosis , ST Elevation Myocardial Infarction/epidemiology , Weather
2.
Catheter Cardiovasc Interv ; 96(3): 638-642, 2020 09 01.
Article in English | MEDLINE | ID: mdl-32315110

ABSTRACT

Percutaneous suture-mediated transcatheter patent fossa ovalis (PFO) closure has been shown to be an effective and safe technique with self-evident advantages due to the lack of a permanent device heart implant. The success of this novel technique relies on an optimal catch of the interatrial septa, especially the septum primum which is floppier than the bulkier muscular septum secundum. We hypothesized that double suture of septum primum would further improve the efficacy of the procedure by increasing the surface contact between the septa when the septum primum is bent into the right atrium. We have provided proof of this concept by implementing a modified technique in two patients with PFO and cerebral ischemic events.


Subject(s)
Brain Ischemia/prevention & control , Cardiac Catheterization , Embolism, Paradoxical/prevention & control , Foramen Ovale, Patent/therapy , Suture Techniques , Adult , Brain Ischemia/etiology , Brain Ischemia/physiopathology , Embolism, Paradoxical/etiology , Embolism, Paradoxical/physiopathology , Female , Foramen Ovale, Patent/complications , Foramen Ovale, Patent/diagnostic imaging , Foramen Ovale, Patent/physiopathology , Humans , Middle Aged , Treatment Outcome
3.
Case Rep Cardiol ; 2019: 5956806, 2019.
Article in English | MEDLINE | ID: mdl-31485355

ABSTRACT

Coronary artery fistulas are rare abnormal connections between a coronary artery and a cardiac chamber or a major vessel. Often, they are asymptomatic and the diagnosis is accidental. The case we present is the incidental finding of a fistula displayed with echocardiography during acute coronary syndrome (ACS). A 73-year-old man presented in the emergency room for non-ST-elevation ACS. Echocardiogram showed in a parasternal short axis view an abnormal diastolic flow inside the ventricular inferior wall. Angiography and CT confirmed the diagnosis of coronary fistula from the right coronary into the left ventricular cavity. A literature analysis with discussion about coronary fistulas classification and management was also performed.

4.
J Cardiovasc Med (Hagerstown) ; 18(5): 291-294, 2017 May.
Article in English | MEDLINE | ID: mdl-28306693

ABSTRACT

Cocaine is associated with important cardiac complications such as sudden death, acute myocarditis, dilated cardiomyopathy, life-threatening arrhythmias, and myocardial ischemia as well as infarction. It is well known that cocaine may induce vasospasm through adrenergic stimulation of the coronary arteries. Moreover, cocaine may promote intracoronary thrombosis, triggered by alterations in the plasma constituents, and platelet aggregation, leading to subsequent myocardial infarction. The long-term use of cocaine may stimulate atherosclerosis, probably through endothelial cell dysfunction. Significant and severe coronary atherosclerosis is common in young chronic cocaine users and there is probably a relationship between the duration and frequency of cocaine use and the extent of coronary disease.


Subject(s)
Central Nervous System Stimulants/adverse effects , Cocaine-Related Disorders/complications , Cocaine/adverse effects , Coronary Artery Disease/chemically induced , Coronary Vasospasm/chemically induced , Coronary Vessels/drug effects , Thrombosis/chemically induced , Thrombosis/diagnostic imaging , Animals , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/physiopathology , Coronary Circulation/drug effects , Coronary Vasospasm/diagnostic imaging , Coronary Vasospasm/physiopathology , Coronary Vessels/diagnostic imaging , Coronary Vessels/physiopathology , Hemodynamics/drug effects , Humans , Prognosis , Risk Assessment , Risk Factors , Thrombosis/physiopathology
5.
Nephrourol Mon ; 7(4): e28099, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26528445

ABSTRACT

CONTEXT: Coronary artery disease is highly prevalent among patients with end stage renal disease/hemodialysis (ESRD/HD) and coronary percutaneous interventions (PCI) has been increased by nearly 50% over the past decade. After PCI with stent placement, guidelines recommend dual antiplatelet therapy (DAPT), but no specifically tailored pharmacotherapy approach is outlined for this frail population, mostly excluded from large randomized clinical trials (RCTs). EVIDENCE ACQUISITION: We reviewed current evidences on the use of antiplatelet therapy in patients with ESRD/HD undergoing PCI, focusing on the efficacy and safety of specific agents and their indications for detailed clinical settings. RESULTS: Clinical setting in HD patients is the principal determinant of the type, onset, combination and duration of the DAPT. However, irrespective clinical setting, in addition to aspirin, clopidogrel is currently the most used antiplatelet agent even if no information derived from RCTs are available in ESRD. Due to the large experience acquired in routine clinical practice, the awareness of safety is higher for clopidogrel than newer antiplatelet agents. Because of lack of data, the use of prasugrel and ticagrelor is actually not recommended. However, in case of high ischemic and acceptable bleeding risk, they may be selectively used in ESRD/HD. CONCLUSIONS: This investigation might contribute to delineate the best treatment options for this high risk population.

SELECTION OF CITATIONS
SEARCH DETAIL
...